# Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors

> **NCT06121752** · NA · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 54 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **PROCEDURE:** Endoscopic submucosal dissection
- **DEVICE:** EFTR

## Key facts

- **NCT ID:** NCT06121752
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-10
- **Primary completion:** 2024-08-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06121752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06121752, "Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06121752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*